Vertex Pharmaceuticals, Inc. (VRTX) Q4 Revenue Beats, FY Guidance Light

January 29, 2014 4:48 PM

Vertex Pharmaceuticals, Inc. (NASDAQ: VRTX) reported Q4 EPS of $0.19, $0.68 better than ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found